Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 1 33-1, 2005, Pages

  Teske, Sabine ^a   Bohn, Andrea A ^b   Regal, Jean F ^c   Neumiller, Joshua J ^a   Lawrence, B Paige ^a,b  

^a College of Pharmacy ^*  (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA DULUTH   (United States)

Author keywords

Adhesion molecules; Aryl hydrocarbon receptor knockout mice; Chemokines; Dioxin; Pulmonary inflammation

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA4 INTEGRIN; AROMATIC HYDROCARBON RECEPTOR; CD11B ANTIGEN; CD31 ANTIGEN; CD38 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT COMPONENT C5A; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; PROTEIN LIX; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INFLUENZA VIRUS A; LUNG DISEASE; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTIGENS, CD; CELL DEATH; CHEMOKINES, CXC; FEMALE; INFLUENZA A VIRUS; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

EID: 20844458617     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00318.2004     Document Type: Article

References (101)

1. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, and Dales RE. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: 349-355, 2001.
2. Anderson RN and Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep 52: 1-85, 2003.
3. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917, 1983.
4. Beebe L, Park SS, and Anderson LM. Differential enzyme induction of mouse liver and lung following a single low or high dose of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD). J Biochem Toxicol 5: 211-219, 1990.
5. Benedict JC, Lin TM, Loeffler IK, Peterson RE, and Flaws JA. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol Sci 56: 382-388, 2000.
6. Bjornson AB, Mellencamp MA, and Schiff GM. Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis 143: 1062-1066, 1991.
7. Burchiel SW and Luster MI. Signaling by environmental polycyclic aromatic hydrocarbons in human lymphocytes. Clin Immunol 8: 2-10, 2001.
8. Burns LA, Bradley SG, White KL Jr, McCay JA, Fuchs BA, Stern M, Brown RD, Musgrove DL, Holsapple MP, Luster MI, and Muson ME. Immunotoxicity of nitrobenzene in female B6C3F1 mice. Drug Chem Toxicol 17: 271-315, 1994.
9. Cai GZ, Griffin GL, Senior RM, Longmore WJ, and Moxley MA. Recombinant SP-D carbohydrate recognition domain is a chemoattractant for human neutrophils. Am J Physiol Lung Cell Mol Physiol 276: L131-L136, 1999.
10. Camacho IA, Hassuneh MR, Nagarkatti M, and Nagarkatti PS. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165: 51-63, 2001.
11. Cataldo DD, Gueders MM, Rocks N, Sounni NE, Evrard B, Bartsch P, Louis R, Noel A, and Foidart JM. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand) 49: 875-884, 2003.
12. Chandrasekar B, Smith JB, and Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103: 2296-2302, 2001.
13. Choi JY, Oughton JA, and Kerkvliet NI. Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Int Immunopharmacol 3: 553-570, 2003.
14. Czermak BJ, Lentsch AB, Bless NM, Schmal H, Friedl HP, and Ward PA. Role of complement in in vitro and in vivo lung inflammatory reactions. J Leukoc Biol 64: 40-48, 1998.
15. Dearstyne EA and Kerkvliet NI. Mechanism of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas, and TNF. Toxicology 170: 139-151, 2002.
16. Denison MS and Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334, 2003.
17. Diaz-Sanchez D, Jyrala M, Ng D, Nel A, and Saxon A. In vivo nasal challenge with diesel exhaust particles enhances expression of the CC chemokines RANTES, MIP-1alpha, and MCP-3 in humans. Clin Immunol 97: 140-145, 2000.
18. Frevert CW, Huang S, Danaee H, Paulauskis JD, and Kobzik L. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 154: 335-344, 1995.
19. Gasiewicz TA and Park SK. Ah Receptor: involvement in toxic responses. In: Dioxins and Health (2nd ed.), edited by Schecter A and Gasiewicz TA. Hoboken, NJ: Wiley-InterScience, 2003, p. 491-532.
20. Geng Y, Savage SM, Johnson LJ, Seagrave J, and Sopori ML. Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 135: 268-278, 1995.
21. Gerde P, Muggenburg BA, Thornton-Manning JR, Lewis JL, Pyon KH, and Dahl AR. Benzo[a]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in tracheal epithelium. Carcinogenesis 18: 1825-1832, 1997.
22. Gilmour MI, Daniels M, McCrillis RC, Winsett D, and Selgrade MK. Air pollutant-enhanced respiratory disease in experimental animals. Environ Health Perspect 109: 619-622, 2001.
23. Hao M, Comier S, Wang M, Lee JJ, and Nel A. Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models. J Allergy Clin Immunol 112: 905-914, 2003.
24. Harrod KS, Jaramillo RJ, Rosenberger CL, Wang SZ, Berger JA, McDonald JD, and Reed MD. Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions. Am J Respir Cell Mol Biol 28: 451-463, 2003.
25. Hartshorn KL, Karnad AB, and Tauber AI. Influenza A virus and the neutrophil: a model of natural immunity. J Leukoc Biol 47: 176-186, 1990.
26. Hartshorn KL and White MR. Influenza A virus up-regulates neutrophil adhesion molecules and adhesion to biological surfaces. J Leukoc Biol 65: 614-622, 1999.
27. Hennet T, Ziltener HJ, Frei K, and Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149: 932-939, 1992.
28. Hierholzer C, Kalff JC, Omert L, Tsukada K, Loeffert JE, Watkins SC, Billiar TR, and Tweardy DJ. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. Am J Physiol Lung Cell Mol Physiol 275: L611-L621, 1998.
29. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, and Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-265, 2004.
30. Kerkvliet NI. Immunotoxicology of dioxins and related chemicals. In: Dioxins and Health (2nd ed.), edited by Schecter A and Gasiewicz TA. Hoboken, NJ: Wiley-Interscience, 2003, p. 299-328.
31. Kerkvliet NI. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2: 277-291, 2002.
32. Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, and DeKrey GK. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8- tetrachlorodibenzo-p-dioxin. J Immunol 157: 2310-2319, 1996.
33. Kerkvliet NI and Burleson GR. Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons. In: Immunotoxicology and Immunopharmacology (2nd ed.), edited by Dean JH, Luster MI, Munson AE, and Kimber I. New York: CRC, 1994, p. 97-121.
34. Kerkvliet NI and Oughton JA. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119: 248-257, 1993.
35. Kerkvliet NI, Shepherd DM, and Baecher-Steppan L. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 185: 146-152, 2002.
36. Kim S and Nadel JA. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat Respir Med 3: 147-159, 2004.
37. Kim SH and Lee CS. Induction of benign and malignant pulmonary tumours in mice with benzo(a)pyrene. Anticancer Res 16: 465-470, 1996.
38. Konstantinos AP and Sheridan JF. Stress and influenza viral infection: modulation of proinflammatory cytokine responses in the lung. Respir Physiol 128: 71-77, 2001.
39. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
40. Lang DS, Becker S, Devlin RB, and Koren HS. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cell Biol Toxicol 14: 23-38, 1998.
41. Lawrence BP and Kerkvliet NI. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57B1/6 mice. Toxicol Sci 42: 13-22, 1998.
42. Lawrence BP, Meyer M, Reed DJ, and Kerkvliet NI. Role of glutathione and reactive oxygen intermediates in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57B1/6 mice. Toxicol Sci 52: 50-60, 1999.
43. Lawrence BP, Warren TK, and Luong H. Fewer T lymphocytes and decreased pulmonary influenza virus burden in mice exposed to 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD). J Toxicol Environ Health A 61: 39-53, 2000.
44. Lee CA, Lawrence BP, Kerkvliet NI, and Rifkind AB. 2,3,7,8- Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses. Toxicol Appl Pharmacol 153: 1-11, 1998.
45. Lee YW, Park HJ, Son KW, Hennig B, Robertson LW, and Toborek M. 2,2′,4,6,6′-Pentachlorobiphenyl (PCB 104) induces apoptosis of human microvascular endothelial cells through the caspase-dependent activation of CREB. Toxicol Appl Pharmacol 189: 1-10, 2003.
46. Legge KL and Braciale TJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18: 265-277, 2003.
47. LeVine AM, Hartshorn K, Elliott J, Whitsett J, and Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 282: L563-L572, 2002.
48. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, and Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 167: 5868-5873, 2001.
49. Li N, Wang M, Oberley TD, Sempf JM, and Nel AE. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J Immunol 169: 4531-4541, 2002.
50. Lin P, Chang YC, Chen CH, Yang WJ, Cheng YH, and Chang LW. A comparative study on the effects of 2,3,7,8,-tetrachlorodibenzo-p-dioxin polychlorinated biphenyl126 and estrogen in human bronchial epithelial cells. Toxicol Appl Pharmacol 195: 83-91, 2004.
51. Luebke RW, Copeland CB, Bishop LR, Daniels MJ, and Gilmour MI. Mortality in dioxin-exposed mice infected with influenza: mitochondrial toxicity (Reye's-like syndrome) versus enhanced inflammation as the mode of action. Toxicol Sci 69: 109-116, 2002.
52. Maeno Y, Mori Y, Iwasa M, Inoue H, and Takabe F. Complement component C3a or C3a desArg as a new marker for estimation of local vital reactions in incised skin wounds. Forensic Sci Int 55: 37-44, 1992.
53. Mannino DM, Homa DM, Akinbami LJ, Ford ES, and Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51: 1-16, 2002.
54. McGuire GM, Liu P, and Jaeschke H. Neutrophil-induced lung damage after hepatic ischemia and endotoxemia. Free Radic Biol Med 20: 189-197, 1996.
55. Mitchell CE, Fischer JP, and Dahl AR. Differential induction of cytochrome P-450 catalyzed activities by polychlorinated biphenyls and benzo[a]pyrene in B6C3F1 mouse liver and lung. Toxicology 43: 315-323, 1987.
56. Moos AB, Steppan-Baecher L, and Kerkvliet NI. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p- dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Toxicol Appl Pharmacol 127: 331-335, 1994.
57. Muppidi J, Porter M, and Siegel RM. Measurement of apoptosis and other forms of cell death. In: Current Protocols in Immunology, edited by Coico R. New York: John Wiley & Sons, 2004, p. 3.7.1-3.7.12.
58. Neff-LaFord HD, Vorderstrasse BA, and Lawrence BP. Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol 226: 54-64, 2003.
59. Ng D, Kokot N, Hiura T, Faris M, Saxon A, and Nel A. Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements. J Immunol 161: 942-951, 1998.
60. Nie M, Blankenship AL, and Giesy JP. Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Environ Toxicol Pharmacol 10: 17-27, 2001,
61. Nohara K, Fujimaki H, Tsukumo S, Inouye K, Sone H, and Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57B1/6 mice. Toxicology 172: 49-58, 2002.
62. Partida-Sanchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B, Kusser K, Goodrich S, Howard M, Harmsen A, Randall TD, and Lund FE. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med 7: 1209-1216, 2001.
63. Patterson RM, Stachlewitz R, and Germolec D. Induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin following endotoxin exposure. Toxicol Appl Pharmacol 190: 120-134, 2003.
64. Perticarari S, Presani G, Mangiarotti MA, and Banfi E. Simultaneous flow cytometric method to measure phagocytosis and oxidative products by neutrophils. Cytometry 12: 687-693, 1991.
65. Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, and Bertazzi PA. Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 55: 126-131, 1998.
66. Pettersen CA and Adler KB. Airways inflammation and COPD: epithelial-neutrophil interactions. Chest 121: 142S-150S, 2002.
67. Pletz MW, Ioanas M, de Roux A, Burkhardt O, and Lode H. Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J 23: 532-537, 2004.
68. Prell RA, Dearstyne E, Steppan LG, Vella AT, and Kerkvliet NI. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis. Toxicol Appl Pharmacol 166: 214-221, 2000.
69. Prell RA, Oughton JA, and Kerkvliet NI. Effect of 2,3,7,8- tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int J Immunopharmacol 17: 951-961, 1995.
70. Puga A, Marlowe J, Barnes S, Chang CY, Maier A, Tan Z, Kerzee JK, Chang X, Strobeck M, and Knudsen ES. Role of the aryl hydrocarbon receptor in cell cycle regulation. Toxicology 181-182: 171-177, 2002.
71. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, and Jetfery PK. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 968-975, 2003.
72. Regal JF and Klos A. Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig. Immunopharmacology 46: 15-28, 2000.
73. Rosen H, Crowley JR, and Heinecke JW. Human neutrophils use the myeloperoxidase-hydrogen peroxide-chloride system to chlorinate but not nitrate bacterial proteins during phagocytosis. J Biol Chem 111: 30463-30468, 2002.
74. Sakai S, Kawamata H, Mantani N, Kogure T, Shimada Y, Terasawa K, Sakai T, Imanishi N, and Ochiai H. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J Virol 74: 2472-2476, 2000.
75. Schagat TL, Wofford JA, Greene KE, and Wright JR. Surfactant protein A differentially regulates peripheral and inflammatory neutrophil chemotaxis. Am J Physiol Lung Cell Mol Physiol 284: L140-L147, 2003.
76. Schmidt JV and Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89, 1996.
77. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Shultz LD, Lamers MC, and Gelfand EW. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 162: 2997-3004, 1999.
78. Senft AP, Dalton TP, Nebert DW, Genter MB, Hutchinson RJ, and Shertzer HG. Dioxin increases reactive oxygen production in mouse liver mitochondria. Toxicol Appl Pharmacol 178: 15-21, 2002.
79. Slezak BP, Hatch GE, DeVito MJ, Diliberto JJ, Slade R, Crissman K, Hassoun E, and Birnbaum LS. Oxidative stress in female B6C3F1 mice following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 54: 390-398, 2000.
80. Soethout EC, Rutten VP, Houwers DJ, de Groot HS, Antonis AF, Niewold TA, and Muller KE. Alpha4-integrin (CD49d) expression on bovine peripheral blood neutrophils is related to inflammation of the respiratory system. Vet Immunol Immunopathol 93: 21-29, 2003.
81. Solhaug A, Refsnes M, Lag M, Schwarze PE, Husoy T, and Holme JA. Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells. Carcinogenesis 25: 809-819, 2004.
82. Stadnyk AW, Dollard C, Issekutz TB, and Issekutz AC. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/ CD18 and CD11b/CD18 co-dependent. Gut 50: 629-635, 2002.
83. Standiford TJ, Kunkel SL, Lukacs NW, Greenberger MJ, Danforth JM, Kunkel RG, and Strieter RM. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol 155: 1515-1524, 1995.
84. Staples JE, Fiore NC, Frazier DE Jr, Gasiewicz TA, and Silverstone AE. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8-tetrachlorodibenzo-p- dioxin. Toxicol Appl Pharmacol 151: 200-210, 1998.
85. Suliman HB, Ryan LK, Bishop L, and Folz RJ. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 280: L69-L78, 2001.
86. Tasaka S, Qin L, Saijo A, Albelda SM, DeLisser HM, and Doerschuk CM. Platelet endothelial cell adhesion molecule-1 in neutrophil emigration during acute bacterial pneumonia in mice and rats. Am J Respir Crit Care Med 167: 164-170, 2003.
87. Tasaka S, Richer SE, Mizgerd JP, and Doerschuk CM. Very late antigen-4 in CD18-independent neutrophil emigration during acute bacterial pneumonia in mice. Am J Respir Crit Care Med 166: 53-60, 2002.
88. Tateda K, Moore TA, Deng JC, Newstead MW, Zeng X, Matsukawa A, Swanson MS, Yamaguchi K, and Standiford TJ. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 166: 3355-3361, 2001.
89. Topping DC, Pal BC, Martin DH, Nelson FR, and Nettesheim P. Pathologic changes induced in respiratory tract mucosa by polycyclic hydrocarbons of differing carcinogenic activity. Am J Pathol 93: 311-324, 1978.
90. Tritscher AM, Mahler J, Portier CJ, Lucier GW, and Walker NJ. Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Pathol 28: 761-769, 2000.
91. Tryphonas H. Immunotoxicity of polychlorinated biphenyls: present status and future considerations. Exp Clin Immunogenet 11: 149-162, 1994.
92. Tsujimoto H, Ono S, Mochizuki H, Aosasa S, Majima T, Ueno C, and Matsumoto A. Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. J Surg Res 103: 61-67, 2002.
93. Van Reeth K, Nauwynck H, and Pensaert M. Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans? J Infect Dis 177: 1076-1079, 1998.
94. Vorderstrasse BA, Bohn AA, and Lawrence BP. Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD. Toxicology 188: 15-28, 2003.
95. Vorderstrasse BA and Kerkvliet NI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol Appl Pharmacol 171: 117-125, 2001.
96. Vorderstrasse BA, Steppan LB, Silverstone AE, and Kerkvliet NI. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171: 157-164, 2001.
97. Warren TK, Mitchell KA, and Lawrence BP. Exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56: 114-123, 2000.
98. Wei C, Caccavale RJ, Weyand EH, Chen S, and Iba MM. Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung. Cancer Lett 178: 25-36, 2002.
99. 100a. World Health Organization. Influenza. /mediacentre/factsheets/ fs211/en/" LOCATOR-TYPE="URL">ww′w.who.int/mediacentre/ factsheets/ fs211/en/ (2003).
100. 100b. World Health Organization. The World Health Report 2003-Shaping the Future. www.who.int/whr/2003 (2003).
101. Yamamoto J, Ihara K, Nakayama H, Hikino S, Satoh K, Kubo N, Iida T, Fujii Y, and Hara T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci 74: 1039-1049, 2004.